Implenia AG (IMPN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 62.90 |
|---|---|
| 52-week range | 57.80 – 83.30 |
| Return, 1 month / 3 months | −2.5% / −3.2% |
| Return, 1 year / 3 years | −2.4% / +155.8% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 36.2% |
| Worst drawdown (1 year) | -27.0% |
| Average daily value traded | 2.78M CHF |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Implenia is a Swiss construction and construction services company based in Opfikon. It builds and renovates buildings and infrastructure such as roads, tunnels, bridges and rail systems, and it carries out civil engineering and tunnelling work. Its customers include public authorities, private developers and industrial clients, mainly in Switzerland and neighbouring European markets. The company also provides related services including real estate development and building technology.
On this site Implenia AG appears as a stock on the SIX Swiss Exchange (Switzerland), code IMPN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Implenia AG (IMPN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 62.90 on 23 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 166 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.4% and over the last three months it fell 3.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -6.3% | ||
| From 52-week high | -23.8% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.2% | ||
| 6-month return | -3.2% | ||
| 12-month return, skipping the last month | 0.0% | ||
| Stability (higher is calmer) | 37 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 36.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.0% | ||
| Liquidity | 59 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.78M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.6% |
|---|---|
| 1 month | −2.5% |
| 3 months | −3.2% |
| 6 months | −3.2% |
| 1 year | −2.4% |
| 3 years | +155.8% |
| 5 years | +253.6% |
Signals
| 50-day / 200-day average | 65.11 / 67.16 |
|---|---|
| Golden / death cross (60 days) | Death, 42 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.79 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | CHF 1.4000 |
| 27 Mar 2025 | CHF 0.9000 |
| 28 Mar 2024 | CHF 0.6000 |
| 30 Mar 2023 | CHF 0.4000 |
| 30 Mar 2020 | CHF 0.6531 |
| 1 Apr 2019 | CHF 0.4354 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.